subscribeSubscribe
Long-Term Drug Shortage – Zerbaxa® (ceftolozane/tazobactam)

Long-Term Drug Shortage – Zerbaxa® (ceftolozane/tazobactam)
PROFESSIONALS
12 Oct 2021
Share Share
Enforcement Report - Week of January 13, 2021

Enforcement Report - Week of January 13, 2021
FDA
13 Jan 2021
Share Share
Enforcement Report - Week of January 6, 2021

Enforcement Report - Week of January 6, 2021
FDA
06 Jan 2021
Share Share
Health Canada Issues Recall Merck Canada Inc`s Zerbaxa

Health Canada Issues Recall Merck Canada Inc`s Zerbaxa

HEALTH CANADA
18 Dec 2020
Share Share
Ceftolozane/tazobactam: New treatment option for severe infections

Ceftolozane/tazobactam: New treatment option for severe infections
MEDICALXPRESS
02 Jul 2020
Share Share
EMA committee recommends approval of Merck`s Zerbaxa 3g dose

EMA committee recommends approval of Merck`s Zerbaxa 3g dose
PHARMABIZ
31 Jul 2019
Share Share
Merck`s treatment for urinary, abdominal infections gets FDA approval

Merck`s treatment for urinary, abdominal infections gets FDA approval
REUTERS
17 Jul 2019
Share Share
Merck`s new combo med Recarbrio fights resistant bacteria

Merck`s new combo med Recarbrio fights resistant bacteria
Eric Sagonowsky FIERCE PHARMA
17 Jul 2019
Share Share
Merck scores a new Zerbaxa indication

Merck scores a new Zerbaxa indication
Eric Sagonowsky FIERCE PHARMA
05 Jun 2019
Share Share
Results of Ph3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam)

Results of Ph3 Trial Evaluating Merck’s ZERBAXA® (ceftolozane and tazobactam)
BUSINESSWIRE
15 Apr 2019
Share Share